Introduction
D-Amino acid oxidase (DAAO) (E.C. 1.4.3.3) can decompose neutral and basic D-amino acid oxidatively to generate hydrogen peroxide (H 2 O 2 ), ammonia, and the corresponding α-keto acid (1, 2) . In mammalian brain tissue, D-serine, an endogenous co-agonist for the ionotropic glutamate receptor N-methyl-Daspartate (NMDA) receptor (3) , is decomposed by DAAO located in astroglial cells (3, 4) . Thus, the brain D-serine concentration controlled by DAAO is crucial for regular neurotransmission via the NMDA receptor, and it has been suggested that a decrease in the D-serine concentration could induce NMDA receptor dysfunction. An example of this is the "glutamate hypothesis", which postulates that the cause of schizophrenia might arise from hypofunction of the NMDA receptor (5) (6) (7) . In fact, the D-serine concentration in serum (8) and cerebrospinal fluids (9) is significantly decreased in schizophrenia patients. In addition, it has recently been reported that DAAO activity is significantly increased in the postmortem brains of schizophrenia patients compared to controls (10) .
DAAO activity in a tissue homogenate is usually assessed by measuring the H 2 O 2 (11) (12) (13) (14) or α-keto acid that is generated after addition of a substrate, D-alanine, or D-proline (10, (15) (16) (17) . Using the increased H 2 O 2 , an oxidative reaction that generates a colorimetric or fluorescent compound in the presence of a peroxidase is performed. Alternatively, the produced α-keto acid is reacted with a hydrazine compound to produce fluorescent or colorimetric substances. The generated substances are then quantified spectrophotometrically. However, both generated H 2 O 2 and α-keto acid require the addition of next-step reagents, such as 2,4-dinitrophenyl hydrazine (DNPH) or Amplex Red ® , for the colorimetric or fluorimetric reaction to proceed.
A previous study by our group has shown that D-kynurenine (D-KYN) is oxidatively deaminated by a standard of pig kidney (pk) DAAO to produce a fluorescent compound, 4-hydroxyquinoline-2-carboxylic acid (kynurenic acid, KYNA) by one-step enzymatic reaction. The corresponding α-keto acid, 2-oxo-4-(2-aminophenyl)-4-oxobutanoic acid may be instantaneously produced as an intermediate in this reaction, but the α-keto acid appears to be immediately thereafter transformed to KYNA by intramolecular cyclization (18) . Thus, the fluorescence intensity of KYNA can be utilized in conjunction with a standard of pig kidney (pk) DAAO in a fluorimetric assay to evaluate several compounds including drugs inhibiting DAAO activity (18, 19) .
The purpose of this study was to investigate the applicability of the proposed assay to rat brain homogenate. Here, we measured DAAO activity in the brain tissues of Sprague-Dawley (SD) rats according to our previously described in vitro assay using D-KYN as the substrate (18) . The inhibition of the DAAO activity by 2 kinds of commercial DAAO inhibitors, as well as the correlation between DAAO mRNA expression and the enzyme activity was examined to determine the reliability of the proposed DAAO assay. Water was purified using a Milli-Q system (Millipore Co. Ltd., Bedford, MA, USA). All other reagents were of reagent grade and were used without further purification.
Materials and Methods

Chemicals
Animal experiments
All animal experiments were approved by the Committee of Animal Care, Toho University (No. 12-51-165). Male Sprague-Dawley (SD) rats were purchased from Charles River Japan (Kanagawa, Japan) and were housed in an environmentally controlled room for at least 1 week before use.
Tissue homogenate preparation
The rats were sacrificed by drawing blood from the abdominal aorta under diethyl-ether anesthesia. The rat brain tissue was immediately dissected and rinsed in a chilled physiological saline. The brain was then divided into cerebrum, cerebellum, and brainstem on an icecooled plate. After weighing each piece, the tissue was homogenized in 10 volumes of chilled Tris buffer (pH 8.3) using a potter-type homogenizer under ice cooling. The prepared homogenates were stored at −80ºC until analysis.
DAAO assay with D-KYN as a substrate
After thawing at 4ºC, an aliquot of 2.0 mL of the homogenate was centrifuged at 600 × g for 30 min, and the obtained supernatant was further centrifuged at 20,000 × g for 20 min. The pellet was suspended in 150 μL of 0.4 M Tris-buffer (pH 8.3) and subjected to the DAAO assay as an enzyme source. The DAAO assay was carried out according to the previously published method (18, 19) with minor modifications.
In The fluorescence of the resultant solution was measured by a HITACHI F-7000 fluorescence spectrophotometer (Hitachi Co. Ltd., Tokyo, Japan). The fluorescence intensity of each solution was measured at an excitation wavelength of 346 nm and (GAPDH; accession number NM017008) gene as an internal control and primers specific for DAAO (accession number NM053626) mRNAs. Upstream primers were CCCTTTCTGGAAAAGCACAG ( D A A O ) a n d G T G G A C C T C AT G G C C TA C AT (GAPDH), and downstream primers were CTCCTC TCACCACCTCTTCG (DAAO) and TGTGAGGGA GATGCTCAGTG (GAPDH). Expression of genes was assessed by real-time RT-PCR using the iQ SYBR Green Supermix and Chrome 4 (Bio-Rad Laboratories Inc., California, CA, USA) running 45 cycles of the following protocol: 3 min predenaturation at 95ºC, 10 sec denaturation at 95ºC, 10 sec at 62ºC, followed by a 1 min extension at 65ºC. The PCR products, DAAO and GAPDH, were purified by 2% agarose gel electrophoresis and subcloned into the pTZ19R vector. After transformation of these recombinants into XL1-Blue by the calcium chloride method, plasmid DNAs were recovered, and their nucleotide sequences were determined by a DNA sequencer, Model 4000 (LI-COR Inc., Lincoln, NE, USA).
Results and Discussion
DAAO activity
In our previous paper, we reported an easy fluorimetric assay for measuring compounds that can inhibit pig kidney DAAO using D-KYN as the substrate (18, 19) . The kynurenic acid (KYNA) produced enzymatically from D-KYN by DAAO emits an intense fluorescence at 396-398 nm in the presence of zinc ions. Thus, the inhibition potency of various compounds against DAAO can be evaluated by the degree of fluorescence produced.
In the present study, this fluorimetric assay was applied to assess the DAAO activity in rat brain tissues. As reported, KYNA emits fluorescence at 396-398 nm with an excitation wavelength at 251 nm (19, 23) or 344-346 nm (24, 25) . An excitation wavelength of 346 nm was used in the present study to increase the signal to noise ratio and to avoid interference fluorescence stemming from endogenous substances included in the brain homogenate. Under the present conditions, a linear calibration curve for standard KYNA in the range of 26.1-81.2 pmol per assay tube was obtained ( Figure  1) , and this calibration curve was used to calculate KYNA production.
To assess DAAO activity in rat brain tissues, the brain tissue homogenates were centrifuged as previously described (15, 17) , and the pellet fraction was then used as an enzyme source for the proposed assay. Increasing concentrations of D-KYN were added to the reactions to determine its optimum concentration as a substrate, which was set at the plateau level of 7.0 mM (Figure 2 ). The pellet fraction was incubated with the D-KYN substrate in Tris buffer (pH 8.3), and an emission wavelength of 396 nm. According to the following equation (1), the ∆F value was determined: ∆F = F -F 0 (1) where F and F 0 are fluorescence intensities of the sample and blank sample (a sample treated without rat brain homogenate), respectively. Based on the ∆F value, the amount of KYNA produced (pmol) was calculated by the calibration curve for KYNA (Figure 1 ). Finally, DAAO activity was expressed as the production rate of KYNA per μg protein (fmol KYNA/min/μg protein), where the protein concentration of the homogenate was determined by the Bradford method according to our previous paper (20) . In the inhibition experiment, the mean fluorescence intensity (∆F) value of the control sample, i.e., the sample without inhibitor, was designated as 100%, and the inhibition degree was expressed as a percentage.
DAAO assay with D-alanine as a substrate
In the conventional DAAO assay using D-alanine as a substrate (10,16) 
Stability of KYNA
In the incubated mixture described in 2.4. Section, 20 μL of KYNA (0.8 mg/mL, 4.2 μM) was added instead of 7.0 mM D-KYN after incubation at 37ºC for 15 min. Samples were then incubated at 37ºC for another 120 min and assayed as previously described. The mean fluorescence intensity (∆F) value of the control sample, i.e., the sample without a pellet fraction, was designated as 100%, and the decreased degree of ∆F was expressed as a percentage.
Real-time quantitative PCR
Total RNAs were extracted from each brain tissue using RNeasy Plus Universal kits (Qiagen, Courtaboeuf, France). Complementary DNAs (cDNAs) were made with a QuantiTect Reverse Transcription kit (Qiagen). DAAO gene expression was determined by RT-PCR using the glyceraldehyde 3-phosphate dehydrogenase the fluorescence intensity of KYNA produced from D-KYN was measured. As shown in Figure 3 , the fluorescence of KYNA at 396 nm increases linearly with time, suggesting that the added D-KYN was converted to KYNA by DAAO present in the pellet fraction. Conversely, incubation with D-KYN alone for 120 min in the absence of the pellet fraction gradually showed fluorescence at 396 nm. Based on this finding, the fluorescence derived from KYNA produced enzymatically from D-KYN by DAAO was calculated by subtracting the fluorescence value without the pellet fraction (blank) from the sample fluorescence intensity at 396 nm. As might be expected, DAAO activity expressed as fmol KYNA/min/μg protein was the highest in rat cerebellum, followed by brain stem and cerebrum (Figure 4 ), in agreement with previous reports (26, 27) .
Although endogenous KYNA is present in rat brain tissues, the concentration is reported to be relatively low, approximately 200-600 fmol/mg protein among the tissues assayed here (28) . In this previous study, a centrifugation fractionation procedure was not carried out, while the assay here uses the pellet fractionby centrifugation. As a result, endogenous KYNA present in the brain tissues hardly affected the fluorescence intensity under the present experimental conditions. Indeed, a blank sample without adding D-KYN consistently showed a background level of fluorescence (Figure 3) .
To determine whether the KYNA produced from D-KYN was further metabolized into other metabolites under the present experimental conditions, a standard of 4.2 μM KYNA instead of D-KYN was added to the enzymatic reaction, and stability of KYNA was investigated. No remarkable decrease in fluorescence intensity of KYNA after the enzymatic reaction at 37ºC for 120 min was observed ( Figure 5 ). In addition, to our knowledge, no information on the metabolites of KYNA in the brain has been reported. Considering these observations, KYNA itself does not appear to be drastically metabolized or decomposed under the present conditions. In the fluorimetric assay, the stability of KYNA that is produced provides an advantage over H 2 O 2 or α-keto acids. Thus, the fluorescence originating from the produced KYNA can be used as a reliable indicator of DAAO activity.
To compare the present data with data obtained by the conventional method, the homogenate sample was also reacted with D-alanine, followed by the addition of 2,4-DNPH, and the absorbance was measured at 445 nm as previously described (21, 22) . Unfortunately, the conventional method failed to assess DAAO activity since the obtained absorbance value hardly differed from the blank value (data not shown). Thus, a more concentrated homogenate sample might be needed to determine DAAO activity by the conventional method. In contrast, the proposed method employs fluorescence detection, allowing brain DAAO activity to be determined in spite of a small amount of homogenate sample.
Inhibition of brain DAAO activity by specific inhibitors
To examine whether the enzymatic formation of KYNA from D-KYN was indeed caused by DAAO or other unknown enzymes, specific inhibitors for DAAO (12, 16) were added to the reaction mixture. 3-Methylpyrazole-5-carboxylic acid (MPC) (12) and 4H-thieno [3,2-b] pyrrole-5-carboxylic acid (Compound 8) (17) were chosen as specific inhibitors in the present study because both compounds are commercially available. Both MPC and Compound 8 (each 100 μM) could completely attenuate the DAAO activity ( Figure  6 ). It has been reported that the IC 50 value of Compound 8 is 114 nM (17) , while that of MPC is 0.91 μM (12), indicating that Compound 8 is a more potent inhibitor of DAAO activity. However, the results from this study ( Figure 6 ) indicated that both specific inhibitors (100 μM) appropriately inhibited the DAAO activity. In contrast, 3-methylpyrazole-4-carboxylic acid (3,4-MPC), a structural isomer of MPC, failed to inhibit the production of KYNA ( Figure 6 ). In agreement with this finding, 3,4-MPC has previously been shown to hardly inhibit pk DAAO in an in vitro study (19) . Taken together, these findings suggest that DAAO in the pellet fraction is responsible for the enzymatic production of KYNA from D-KYN.
R e c e n t l y, a n i n v i v o m i c r o d i a l y s i s s t u d y demonstrated that D-KYN was metabolized to KYNA in rat striatum by kynurenine aminotransferase (KAT) based on evidence showing that addition of an inhibitor of KAT, AOAA, remarkably inhibited KYNA production from D-KYN (29) . Considering this recent report, the effect of AOAA on the production of KYNA from D-KYN in our brain homogenates was investigated. As shown in Figure 7 , however, no considerable decrease in the production of KYNA by D-KYN was observed in the present study with the addition of AOAA. Therefore, it seems unlikely that KAT contributed to the production of KYNA under the present experimental conditions. The reason for this discrepancy is unknown, but it may stem from differences between the in vivo state examined in the first study and the homogenates examined here, which are not at physiological pH, but at a weakly basic pH in Tris buffer (pH 8.3).
mRNA expression
In addition to DAAO activity, DAAO mRNA expression was also investigated by real-time quantitative PCR. Table 1 shows DAAO activity and mRNA expression in the cerebrum, brainstem, and cerebellum of SD rats. The present data revealed a similar tendency to those reported previously (30, 31) , namely, the highest DAAO mRNA expression was found in the cerebellum, while slight expression was observed in the cerebrum. DAAO mRNA expression plotted against DAAO activity, as shown in Figure 8 , reveals a linear relationship between DAAO mRNA and DAAO activity (r = 0.9982), indicating that the DAAO activity shown by the present assay might be reflected in DAAO expression in rat brain.
In summary, DAAO activity in the cerebrum, cerebellum, and brainstem of rats can be measured by an easy fluorimetric assay using D-KYN as a substrate. The produced KYNA was stable in the homogenate under the current experimental conditions. Recently, Wong et al. reported a microplate fluorescence assay for KAT I using fluorescence originating from KYNA (32) . Since the fluorimetric assay proposed here also uses the fluorescence of KYNA, a rapid microplate version of this assay will be performed with a plate reader in the future. Figure 8 . Expression of DAAO mRNA plotted against the DAAO activity in the cerebrum (circle), brainstem (triangle), and cerebellum (square) determined by the proposed assay (n = 5).
